Loading clinical trials...
Loading clinical trials...
A Multicenter Randomized Open Label Study to Assess Efficacy and Safety of a Steroid Avoidance Regimen in Comparison to a Treatment With Steroids, in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS) 2.16 g/d for 6 Weeks and Cyclosporine Microemulsion, in de Novo Adult Renal Transplant Recipients
Conditions
Interventions
Enteric-coated mycophenolate sodium (EC-MPS)
Prednisone
Locations
1
France
C.H.U. La Milétrie
Poitiers, France
Start Date
April 1, 2007
Primary Completion Date
March 1, 2009
Last Updated
April 21, 2011
NCT07294183
NCT05086003
NCT03478215
NCT03504241
NCT04774575
NCT05208788
Lead Sponsor
Novartis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions